Trial for immunotherapy drug shows promise for aggressive breast cancer
University of Hawaiʻi Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms of breast cancer. The ...
9 hours ago
0
9